Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer

被引：0
|
作者：
Rima Patel
Zhiqiang Li
Brittney S. Zimmerman
Marc Y. Fink
Jason D. Wells
Xiang Zhou
Kristin Ayers
Arielle Redfern
Scott Newman
Eric Schadt
William K. Oh
Rong Chen
Amy Tiersten
机构：
[1] Icahn School of Medicine at Mount Sinai,Division of Hematology and Medical Oncology
[2] Sema4,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 192卷
关键词：
Metastatic breast cancer; Obesity; Aromatase inhibitors; Hormone positive breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：313 / 319
页数：6
相关论文
共 50 条
  • [41] Efficacy and Safety of Monthly Minodronate Therapy in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
    Ogata, Nanae
    Toh, Uhi
    Sudou, Tomoya
    Ogata, Suguru
    Takao, Yuko
    Sugihara, Rie
    Watanabe, Hideaki
    Matushima, Shuntaro
    Akagi, Yoshito
    ANTICANCER RESEARCH, 2022, 42 (08) : 4139 - 4143
  • [42] Impact of body mass index on compliance and persistence to adjuvant breast cancer therapy
    Schmid, Seraina Margaretha
    Eichholzer, Monika
    Bovey, Florence
    Myrick, Mary Elizabeth
    Schoetzau, Andreas
    Gueth, Uwe
    BREAST, 2012, 21 (04) : 487 - 492
  • [43] Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations
    Maugeri-Sacca, Marcello
    Barba, Maddalena
    Vici, Patrizia
    Pizzuti, Laura
    Sergi, Domenico
    De Maria, Ruggero
    Di Lauro, Luigi
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (02) : 227 - 235
  • [44] Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations
    Marcello Maugeri-Saccà
    Maddalena Barba
    Patrizia Vici
    Laura Pizzuti
    Domenico Sergi
    Ruggero De Maria
    Luigi Di Lauro
    Breast Cancer Research and Treatment, 2014, 147 : 227 - 235
  • [45] Impact of Body Mass Index on Prognostically Relevant Breast Cancer Tumor Characteristics
    Eichholzer, Monika
    Huang, Dorothy J.
    Modlasiak, Alexandra
    Schmid, Seraina M.
    Schoetzau, Andreas
    Rohrmann, Sabine
    Gueth, Uwe
    BREAST CARE, 2013, 8 (03) : 192 - 198
  • [46] Impact of Body Mass Index on Survival of Pancreatic Cancer Patients in Japan
    Okura, Tomohiro
    Fujii, Masakuni
    Shiode, Junji
    Ito, Yuri
    Kojima, Toru
    Nasu, Junichiro
    Niguma, Takefumi
    Yoshioka, Masao
    Mimura, Tetsushige
    Yamamoto, Kazuhide
    ACTA MEDICA OKAYAMA, 2018, 72 (02) : 129 - 135
  • [47] Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors
    Batalo, Michael
    Nagaiah, Govardhanan
    Abraham, Jame
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (08) : 1277 - 1282
  • [48] Aromatase inhibitors and breast cancer prevention
    Litton, Jennifer Keating
    Arun, Banu K.
    Brown, Powel H.
    Hortobagyi, Gabriel N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (03) : 325 - 331
  • [49] Aromatase Inhibitors in Breast Cancer Prevention
    Olin, Jacqueline L.
    St Pierre, Melani
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (12) : 1605 - 1610
  • [50] The association of body mass index and adverse clinicopathological characteristics in non-metastatic breast cancer
    Abusanad, Atlal
    Alghamdi, Bashayer
    Alghamdi, Reema
    Khallaf, Raghad
    Faisal, Konooz
    Bishnaq, Raghad
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (08) : 4190 - 4195
12345